This newslink doesn't exist or it was removed.
Go to Homempage.
MarketWatch USA Business October 02, 2023
In recent days, Wall Street analysts speculated that a world slimmed by the so-called GLP-1 drugs would be bullish for airlines such as (ticker: UAL)—as lighter passengers save fuel—and bearish for restaurant plays such as the software vendor (TOST)—as customers eat out... + más
What Are the Duties of A Trustee? | Forbes
Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek
Orlando Sentinel USA Nation December 06, 2022
Florida ha visto un ligero aumento en los casos de COVID-19 durante la semana del Día de Acción de Gracias y la semana posterior. Se registraron 30,932 nuevos casos de COVID-19 durante las últimas dos semanas entre los residentes de Florida, en comparación con los 23,486... + más
Una catástrofe estadounidense | The Atlantic
Tesla's close-knit leadership team goes under the spotlight in court | CNN
The New York Times USA Health September 29, 2022
On Wednesday, Katie Couric revealed that she had breast cancer. In , she wrote about the “heart-stopping, suspended animation feeling” she had upon receiving her diagnosis in June; she also noted that she had dense breasts — a common classification that can increase the... + más
Transgender young people feel less distress after gender-confirming surgery, Northwestern study says | Chicago Tribune
Classic movie has town busting out changes to lewdness law | Associated Press
MarketWatch USA Business October 05, 2023
The negativity has been driven largely by the concern that widespread use of GLP-1 drugs like Ozempic and Wegovy will mean less insulin use and more stable blood glucose levels among type 2 diabetes patients, shrinking the market for diabetes devices. Shares of diabetes device... + más
NBA playoffs 2023: Our insiders dissect the Eastern and Western conference finals | ABC7
MarketWatch USA Business September 21, 2023
Outside the GLP-1 revels, their echo casts gloom over shares of businesses that grew with America’s waistlines. Insulin-pump makers (PODD) and (TNDM) are down 40% and 50% this year, respectively, while the glucose monitor leader (DXCM) has lost 16%. (RMD) dominates the devices... + más
A New Genetic Test Could Help Doctors Prescribe Weight Loss Drugs | Time
New guidance: Use drugs, surgery early for obesity in kids | ABC News
About iurex | Privacy Policy | Disclaimer |